These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical pharmacist impact on care, length of stay, and cost in pediatric cystic fibrosis (CF) patients. Cies JJ; Varlotta L Pediatr Pulmonol; 2013 Dec; 48(12):1190-4. PubMed ID: 23281228 [TBL] [Abstract][Full Text] [Related]
26. [Antibiotic treatment of cystic fibrosis exacerbations]. Dumcius S Medicina (Kaunas); 2003; 39(3):221-4. PubMed ID: 12695633 [TBL] [Abstract][Full Text] [Related]
27. Home intravenous antibiotic treatment in cystic fibrosis. Strandvik B; Hjelte L; Widén B Scand J Gastroenterol Suppl; 1988; 143():119-20. PubMed ID: 3164495 [TBL] [Abstract][Full Text] [Related]
28. Intravenous antibiotic therapy in cystic fibrosis: in hospital or at home? Peckham D; Knox A Respir Med; 1993 Jul; 87(5):329-30. PubMed ID: 8209051 [No Abstract] [Full Text] [Related]
29. Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Ryan G; Mukhopadhyay S; Singh M Cochrane Database Syst Rev; 2000; (2):CD001021. PubMed ID: 10796732 [TBL] [Abstract][Full Text] [Related]
30. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Høiby N; Koch C Thorax; 1990 Nov; 45(11):881-4. PubMed ID: 2256020 [No Abstract] [Full Text] [Related]
32. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy. Levy J Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160 [TBL] [Abstract][Full Text] [Related]
33. A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis. Valletta EA; Rigo A; Bonazzi L; Zanolla L; Mastella G Acta Univ Carol Med (Praha); 1990; 36(1-4):44-5. PubMed ID: 2130717 [TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis. Conway SP; Etherington C; Munday J; Goldman MH; Strong JJ; Wootton M Ann Pharmacother; 2000 Nov; 34(11):1238-42. PubMed ID: 11098334 [TBL] [Abstract][Full Text] [Related]
35. Adverse reactions to piperacillin in adults with cystic fibrosis. Stead RJ; Kennedy HG; Hodson ME; Batten JC Thorax; 1985 Mar; 40(3):184-6. PubMed ID: 3983886 [TBL] [Abstract][Full Text] [Related]
36. Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics. Vinks AA; Brimicombe RW; Heijerman HG; Bakker W J Antimicrob Chemother; 1997 Jul; 40(1):125-33. PubMed ID: 9249216 [TBL] [Abstract][Full Text] [Related]
38. [Making antibiotic therapy easier to use. A welcome advance for those with cystic fibrosis]. Sabourin G Perspect Infirm; 2011; 8(4):54-5. PubMed ID: 21812190 [No Abstract] [Full Text] [Related]
39. Use of carbenicillin in patients with cystic fibrosis. Boxerbaum B; Doershuk CF; Matthews LW J Infect Dis; 1970 Sep; 122():Suppl:S59-61. PubMed ID: 4990025 [No Abstract] [Full Text] [Related]
40. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D; Stableforth D Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]